Search for: "BENEFIT v. PFIZER, INC." Results 41 - 60 of 201
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Apr 2015, 1:11 pm
After conducting “a comprehensive review of the risks and benefits” of Children’s Motrin, the FDA “agreed with the petitioners that the labeling of . . . [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
9 Apr 2015, 5:00 am
  Two other state supreme courts have reaffirmed the learned intermediary rule since then, Wyeth, Inc. v. [read post]
31 Dec 2014, 5:00 am
                  Ortho-McNeil-Janssen Pharmaceutical, Inc. v. [read post]
7 Nov 2014, 5:52 am
 A warning about an inherent risk – a so-called “risk warning” – serves an entirely different purpose.With inherent risks, people are warned so they can decide whether that risk outweighs the benefits that might be gained from using the product. [read post]
21 Jul 2014, 12:06 pm
PLIVA, Inc., 713 F.3d 774, 777 (5th Cir. 2013) (citing Buckman Co. v. [read post]
18 Jul 2014, 11:55 am
Pfizer, Inc., 716 F.3d 1087, 1092-93 (8th Cir. 2013). [read post]
23 Jun 2014, 12:57 pm by Schachtman
Thus, for diseases for which the causes are largely unknown, such as most birth defects, a differential etiology is of little benefit. [read post]
12 Jun 2014, 3:11 pm by Schachtman
Pfizer Pharms., Inc., 2011 WL 7659333, at *6-10 (S.D. [read post]
22 May 2014, 5:00 am
Pfizer, Inc., 2000 WL 1099884, at *2 & n.1 (S.D.N.Y. [read post]